Phase 2

Marker Therapeutics Secures $13.1M Grant To Support MultiTAA Cell Therapy Trial

Paratek's Antibiotic Gets FDA Orphan Drug Tag For Lung Infection

Galecto Starts Dosing In Mid-Stage Myelofibrosis Trial

Paratek's Antibiotic Gets FDA Orphan Drug Tag For Lung Infection

Galecto Starts Dosing In Mid-Stage Myelofibrosis Trial

DMC Recommends Biophytis Continue Sarconeos COVID-19 Study

Frequency Therapeutics Stock Craters After FX-322's Four Weekly Regime Shows No Benefit In Sensorineural Hearing Loss

DMC Recommends Biophytis Continue Sarconeos COVID-19 Study

Frequency Therapeutics Stock Craters After FX-322's Four Weekly Regime Shows No Benefit In Sensorineural Hearing Loss

AnaptysBio's Imsidolimab Fails To Separate From Placebo In Skin Blistering Disorder Study

Chimerix's DSTAT Shows Promising Results In First Cohort Of COVID-19 Study

Phase 2 Recent News

Revance Therapeutics' DaxibotulinumtoxinA For Injection Improves Muscle Tone In Mid-Stage Upper Limb Spasticity

Nektar Therapeutics Secures $150M From SFJ Pharma For New Study With BEMPEG/Pembrolizumab Combo In Head & Neck Cancer

Clene To Start Testing CNM-ZnAg In COVID-19 Patients In Brazil

Windtree Therapeutics' AEROSURF Drug Delivery Device Secures US Patent

Exelixis' Cabozantinib Data Shows Clinically Significant Benefit Versus Pfizer's Sutent, In A Type Of Kidney Cancer

Cortexyme Stops Enrollment In Mid-Stage Atuzaginstat Study In Alzheimer's Disease

Heat Biologics Cell Therapy Shows Survival Benefit In Mid-Stage Lung Cancer Study, Shares Rally

Innate Pharma To Test Lacutamab In Relapsed/Refractory Peripheral T-Cell Lymphoma Patients

Otonomy Rips 90% After Meniere's Disease Drug Achieves Primary Endpoint

Ironwood's Pipeline Needs Work, Analyst Downgrades

Getting Into The Drug Business: From NDAs To PDUFA Dates

Synthetic Biologics Crashes Following Disappointing Phase 2 Results

Novo Nordisk Announces Positive Phase 2 Trial Results, Shares Spike Higher